These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9785591)

  • 21. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
    Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
    Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
    Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
    J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
    Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
    Kanamaru K; Weir BK; Simpson I; Witbeck T; Grace M
    J Neurosurg; 1991 Mar; 74(3):454-9. PubMed ID: 1993911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
    Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
    Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage.
    Kawada S; Kinugasa K; Meguro T; Hirotsune N; Tokunaga K; Kamata I; Nakashima H; Ohmoto T
    Acta Neurochir (Wien); 1999; 141(12):1331-8. PubMed ID: 10672305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model.
    Xu H; Chen X; Qin Z; Gu Y; Zhou P
    Acta Neurochir (Wien); 2011 Jun; 153(6):1333-8; discussion 1338. PubMed ID: 21311917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage.
    Ikeda K; Asakura H; Futami K; Yamashita J
    Neurosurgery; 1997 Aug; 41(2):344-9; discussion 349-50. PubMed ID: 9257301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
    Afshar JK; Pluta RM; Boock RJ; Thompson BG; Oldfield EH
    J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
    Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
    J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.
    Zhang ZD; Yamini B; Komuro T; Ono S; Johns L; Marton LS; Weir B; Macdonald RL
    Stroke; 2001 Aug; 32(8):1868-74. PubMed ID: 11486119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates.
    Handa Y; Kaneko M; Takeuchi H; Tsuchida A; Kobayashi H; Kubota T
    Surg Neurol; 2000 Apr; 53(4):323-9. PubMed ID: 10825515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
    Nosko M; Weir BK; Lunt A; Grace M; Allen P; Mielke B
    J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
    Horky LL; Pluta RM; Boock RJ; Oldfield EH
    J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings.
    Nosko M; Weir B; Krueger C; Cook D; Norris S; Overton T; Boisvert D
    Neurosurgery; 1985 Feb; 16(2):129-36. PubMed ID: 3974822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
    Seifert V
    Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.